Neuroscience
The Neuroscience Clinical Trials Team conducts clinical trials for patients with dementia, epilepsy, migraine and headache disorders, stroke, movement disorders and other neurological conditions.
CB03: add-on therapy for focal epilepsy
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Primary Generalized Tonic-Clonic Seizures
A disease modification drug for Temporal Lobe Epilepsy
A disease modification drug for Temporal Lobe Epilepsy
Do you have generalised epilespy?
This study is trialing a novel anti-epileptic medication called XEN1101 in patients who suffer from primary generalized tonic-clonic seizures and have not achieved satisfactory seizure control using standard therapies.
Do you have focal epilespy?
This study is trialing a novel anti-epileptic medication called XEN1101 in focal epilepsy patients who have not achieved satisfactory seizure control on at least two anti-epileptic medications.